Press coverage about National Health Investors (NYSE:NHI) has trended somewhat positive recently, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. National Health Investors earned a news sentiment score of 0.16 on Accern’s scale. Accern also assigned news headlines about the real estate investment trust an impact score of 45.4581396568373 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
These are some of the media stories that may have impacted Accern’s scoring:
- NHI to Attend REITWorld 2017 in Dallas, TX (finance.yahoo.com)
- ValuEngine Upgrades National Health Investors, Inc. (NHI) to “Buy” (americanbankingnews.com)
- FY2017 Earnings Forecast for National Health Investors, Inc. (NHI) Issued By SunTrust Banks (americanbankingnews.com)
- National Health Investors, Inc. Plans Quarterly Dividend of $0.95 (NHI) (americanbankingnews.com)
- NHI says Q3 FFO per share $1.35 – Times of India (timesofindia.indiatimes.com)
Several analysts have recently commented on NHI shares. Zacks Investment Research cut National Health Investors from a “buy” rating to a “sell” rating in a research report on Tuesday, July 18th. Mizuho reissued a “hold” rating and set a $82.00 price objective on shares of National Health Investors in a research report on Wednesday, October 4th. SunTrust Banks, Inc. initiated coverage on National Health Investors in a research report on Tuesday, October 10th. They set a “hold” rating and a $80.00 price objective for the company. BidaskClub upgraded National Health Investors from a “sell” rating to a “hold” rating in a report on Thursday, August 17th. Finally, KeyCorp restated a “hold” rating on shares of National Health Investors in a report on Sunday, September 17th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $80.14.
Shares of National Health Investors (NYSE:NHI) traded up $0.23 on Friday, reaching $76.66. The company had a trading volume of 223,200 shares, compared to its average volume of 192,348. The company has a quick ratio of 12.45, a current ratio of 12.72 and a debt-to-equity ratio of 0.84. The company has a market capitalization of $3,183.84, a price-to-earnings ratio of 14.71, a price-to-earnings-growth ratio of 3.79 and a beta of 0.58. National Health Investors has a 1 year low of $67.33 and a 1 year high of $81.21.
National Health Investors (NYSE:NHI) last released its quarterly earnings data on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share for the quarter, missing analysts’ consensus estimates of $1.29 by ($0.36). The company had revenue of $69.84 million for the quarter, compared to analyst estimates of $67.68 million. National Health Investors had a net margin of 59.70% and a return on equity of 12.74%. The firm’s revenue for the quarter was up 14.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.22 earnings per share. equities research analysts expect that National Health Investors will post 5.25 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 31st. Shareholders of record on Friday, December 29th will be issued a dividend of $0.95 per share. This represents a $3.80 dividend on an annualized basis and a yield of 4.96%. The ex-dividend date is Thursday, December 28th. National Health Investors’s payout ratio is 95.00%.
In other news, insider Kevin Carlton Pascoe sold 2,000 shares of the business’s stock in a transaction that occurred on Thursday, August 24th. The stock was sold at an average price of $79.80, for a total value of $159,600.00. Following the transaction, the insider now directly owns 21,228 shares of the company’s stock, valued at approximately $1,693,994.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 5.19% of the stock is owned by insiders.
National Health Investors Company Profile
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.